Clinical Research

Clinical Trials Drug Development Drug Efficacy Randomized Controlled Trials Drug Trials Studies Patient Outcomes Patient Studies Animal Studies Therapeutics

NADPH Disruption Fuels Early Pancreatic Lesions as ME1 Loss Drives Cancer Progression

The preclinical results point to redox metabolism as a route to spot or halt early pancreatic disease.

Stories older than 24h

Mirtazapine Modestly Cuts Meth Use in Phase III Trial

Engineered ‘SimCells’ Target Drug-Resistant Bacteria With Dual-Action Attack

GLP-1 Drugs Linked to Lower Addiction Risk and Harm in Large VA Study

Heart Pump Before Stenting Shows No Benefit in STEMI Without Shock

Autolus Reports Q4 Loss, Reaffirms 2026 Sales Outlook for AUCATZYL, and Starts AUTO8 Trial

Wave Life Sciences Shares Plunge 30% After Early Obesity Trial Readout

FDA Grants Accelerated Approval to Avlayah for Neurologic Manifestations of Hunter Syndrome

Millisecond Acetylcholine Timing Splits Dopamine’s Roles in Learning and Movement

Colitis Leaves Lasting Epigenetic Scars That Speed Colon Tumor Growth in Mice

Sanofi Licenses Kali’s Tri-Specific Autoimmune Antibody KT501 in Deal Worth Up to $1.23 Billion

Walking Test Finds Gait Patterns That Help Tell Lewy Body Dementia From Parkinson’s

Aging and Parkinson’s Shift Balance Control to the Cortex, Weakening Recovery

Large Meta-Analysis Finds No Link Between Psychosocial Factors and Overall Cancer Risk

Novartis Strikes $2 Billion Deal for Mutant-Selective PI3Kα Cancer Drug SNV4818

Hypertensive Heart Disease Deaths in U.S. Women 25–44 Quadrupled Since 1999, Study Finds

Health Universe Raises $6 Million Led by Kleiner Perkins to Scale Auditable Healthcare AI

Serina Therapeutics Shares Jump After Private Placement to Raise Up to $63.3 Million

Six-Week Postpartum Surveillance Reveals 40% More Severe Maternal Complications in Ontario

EltaMD Debuts SPF 50 for Blemish‑Prone, Oily Skin on National Dermatologist Day